Czech National Bank Increases Position in Stryker Corporation $SYK

Czech National Bank boosted its position in Stryker Corporation (NYSE:SYK) by 3.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 90,755 shares of the medical technology company’s stock after acquiring an additional 3,366 shares during the period. Czech National Bank’s holdings in Stryker were worth $31,898,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Brighton Jones LLC increased its stake in Stryker by 15.4% in the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after purchasing an additional 609 shares during the last quarter. Schnieders Capital Management LLC. acquired a new stake in Stryker in the 2nd quarter worth about $205,000. Global Retirement Partners LLC purchased a new stake in Stryker in the 2nd quarter valued at about $2,504,000. CreativeOne Wealth LLC grew its holdings in Stryker by 22.4% in the 2nd quarter. CreativeOne Wealth LLC now owns 5,464 shares of the medical technology company’s stock valued at $2,162,000 after buying an additional 999 shares during the period. Finally, Insigneo Advisory Services LLC increased its stake in shares of Stryker by 35.3% during the 2nd quarter. Insigneo Advisory Services LLC now owns 1,220 shares of the medical technology company’s stock valued at $483,000 after acquiring an additional 318 shares during the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on SYK shares. Robert W. Baird set a $437.00 target price on shares of Stryker in a research report on Friday, January 30th. TD Cowen lowered shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 price target for the company. in a research report on Monday, January 26th. Barclays reaffirmed an “overweight” rating and set a $469.00 price target on shares of Stryker in a research note on Monday, February 2nd. Needham & Company LLC lifted their price target on shares of Stryker from $448.00 to $454.00 and gave the company a “buy” rating in a report on Friday, January 30th. Finally, BTIG Research upped their price objective on Stryker from $410.00 to $412.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Fourteen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $427.50.

Stryker Trading Down 0.4%

Shares of SYK stock opened at $327.34 on Thursday. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. Stryker Corporation has a fifty-two week low of $324.93 and a fifty-two week high of $404.87. The firm’s 50 day moving average price is $361.50 and its two-hundred day moving average price is $364.58. The stock has a market cap of $125.37 billion, a price-to-earnings ratio of 38.97, a price-to-earnings-growth ratio of 1.92 and a beta of 0.85.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating analysts’ consensus estimates of $4.40 by $0.07. The business had revenue of $7.17 billion for the quarter, compared to the consensus estimate of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The business’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter last year, the firm posted $4.01 EPS. On average, analysts anticipate that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be given a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s dividend payout ratio (DPR) is 41.90%.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total value of $90,730,000.00. Following the completion of the sale, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. This represents a 9.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 5.90% of the stock is currently owned by corporate insiders.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.